Cellectar Biosciences, Inc. (CLRB)
3.14
+0.05
(+1.62%)
USD |
NASDAQ |
May 18, 16:00
3.10
-0.04
(-1.27%)
After-Hours: 20:00
Cellectar Biosciences EPS Diluted (Quarterly) : -1.333 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Karyopharm Therapeutics, Inc. | -1.236 |
| Ocugen, Inc. | -0.0586 |
| Invivyd, Inc. | -0.1337 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.654M |
| Total Expenses (Quarterly) | 5.654M |
| Enterprise Value | 8.398M |
| Earnings Yield | -234.8% |
| Normalized Earnings Yield | -245.84 |